REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC)

CUSIP: G8708A116

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Stock
Total 13F shares
3,828,712
Share change
-125,554
Total reported value
$39,629,000
Price per share
$10.35
Number of holders
21
Value change
-$1,301,970
Number of buys
4
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP G8708A116?
CUSIP G8708A116 identifies TZAC - REVIVA PHARMACEUTCLS HLDGS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) as of Q3 2019

As of 30 Sep 2019, REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,828,712 shares. The largest 10 holders included MIZUHO SECURITIES USA LLC, Karpus Management, Inc., OXFORD ASSET MANAGEMENT LLP, BANK OF AMERICA CORP /DE/, BANK OF MONTREAL /CAN/, Periscope Capital Inc., Shaolin Capital Management LLC, BOOTHBAY FUND MANAGEMENT, LLC, GABELLI & Co INVESTMENT ADVISERS, INC., and Cowen Investment Management LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.